Caren Deardorf - Mar 11, 2022 Form 3 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Role
Director
Signature
/s/Marc Wilson, as attorney-in-fact
Stock symbol
CRNX
Transactions as of
Mar 11, 2022
Transactions value $
$0
Form type
3
Date filed
3/14/2022, 05:18 PM
Previous filing
Feb 17, 2022
Next filing
May 19, 2022

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power-of-Attorney